BRIGHTMEM
Live / Applied — Statement of use — registration review complete (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 07 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98168570
- Mark type
- Stylized text
- Filed
- 07 Sept 2023
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Andrew D. Dorisio
Goods and services
- Class 005 — Pharmaceuticals: Human allograft tissue
Owner
- Brightstar Therapeutics Inc., Lexington, KY, US
- Brightstar Therapeutics Inc., Lexington, KY, US
Prosecution history
- 02 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Sept 2025 — USE AMENDMENT FILED
- 21 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 31 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 2 GRANTED
- 30 Jul 2025 — SOU EXTENSION 2 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2024 — SOU EXTENSION 1 GRANTED